Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
$58.40
$51.77
$19.50
$59.76
$22.57B0.26175 shsN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$28.34
-0.2%
$35.67
$27.18
$56.21
$2.23B1.12702,279 shs434,684 shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$14.14
+2.1%
$15.04
$11.03
$21.22
$1.81B1.1893,584 shs807,017 shs
Envista Holdings Co. stock logo
NVST
Envista
$20.39
+1.8%
$21.00
$18.95
$38.68
$3.50B1.352.30 million shs1.82 million shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
0.00%0.00%+5.43%+31.35%+102.60%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
-3.30%-10.18%-15.82%-32.10%-47.58%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-1.28%+0.58%-8.64%-11.27%-3.82%
Envista Holdings Co. stock logo
NVST
Envista
-1.28%+1.37%-3.54%-17.82%-47.30%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.8097 of 5 stars
3.13.00.04.02.91.73.8
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.3005 of 5 stars
3.41.00.00.03.62.50.6
Envista Holdings Co. stock logo
NVST
Envista
4.6574 of 5 stars
4.04.00.03.83.20.01.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.22
Hold$44.8958.39% Upside
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.80
Moderate Buy$19.5037.91% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.00
Hold$27.9036.83% Upside

Current Analyst Ratings

Latest NEO, BTGGF, NVST, and IART Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Envista Holdings Co. stock logo
NVST
Envista
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$33.00 ➝ $21.00
4/3/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$38.00
3/1/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$46.00 ➝ $41.00
2/29/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $49.00
2/26/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$18.00 ➝ $20.00
2/26/2024
Envista Holdings Co. stock logo
NVST
Envista
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform
2/26/2024
Envista Holdings Co. stock logo
NVST
Envista
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderperform$19.00
2/22/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$17.00 ➝ $19.00
2/21/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/21/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$21.00 ➝ $24.00
2/9/2024
Envista Holdings Co. stock logo
NVST
Envista
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$30.00 ➝ $23.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.54B1.44$4.65 per share6.09$20.31 per share1.40
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$591.64M3.05$0.28 per share49.70$7.39 per share1.91
Envista Holdings Co. stock logo
NVST
Envista
$2.57B1.37$2.56 per share7.97$24.35 per share0.84

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/A0.00N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M$0.8334.147.850.884.39%15.19%6.59%5/6/2024 (Confirmed)
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$87.97M-$0.70N/AN/AN/A-14.87%-4.13%-2.33%4/30/2024 (Confirmed)
Envista Holdings Co. stock logo
NVST
Envista
-$100.20M-$0.61N/A12.593.79-3.90%6.31%4.07%5/1/2024 (Confirmed)

Latest NEO, BTGGF, NVST, and IART Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.55N/A-$0.55N/AN/AN/A  
5/1/2024N/A
Envista Holdings Co. stock logo
NVST
Envista
$0.31N/A-$0.31N/AN/AN/A  
4/30/2024N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$0.0270N/A+$0.0270N/AN/AN/A  
2/28/202412/31/2023
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.90$0.89-$0.01$1.53$399.30 million$397.00 million    
2/20/2024Q4 2023
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$0.07-$0.02+$0.05$0.07$152.90 million$155.55 million
2/7/2024Q4 2023
Envista Holdings Co. stock logo
NVST
Envista
$0.33$0.29-$0.04$1.85$638.37 million$645.60 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.94
3.45
2.18
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.57
6.20
5.95
Envista Holdings Co. stock logo
NVST
Envista
0.33
2.23
1.90

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%
Envista Holdings Co. stock logo
NVST
Envista
N/A

Insider Ownership

CompanyInsider Ownership
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
1.30%
Envista Holdings Co. stock logo
NVST
Envista
1.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
35386.49 millionN/ANot Optionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94678.60 million76.17 millionOptionable
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,100127.67 million126.01 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,800171.86 million169.62 millionOptionable

NEO, BTGGF, NVST, and IART Headlines

SourceHeadline
Envista (NYSE:NVST) Shares Gap Down to $20.02Envista (NYSE:NVST) Shares Gap Down to $20.02
marketbeat.com - April 26 at 4:42 PM
Envista (NYSE:NVST) Stock Rating Lowered by Morgan StanleyEnvista (NYSE:NVST) Stock Rating Lowered by Morgan Stanley
marketbeat.com - April 26 at 7:18 AM
Bfsg LLC Makes New Investment in Envista Holdings Co. (NYSE:NVST)Bfsg LLC Makes New Investment in Envista Holdings Co. (NYSE:NVST)
marketbeat.com - April 25 at 11:36 AM
48,100 Shares in Envista Holdings Co. (NYSE:NVST) Purchased by Louisiana State Employees Retirement System48,100 Shares in Envista Holdings Co. (NYSE:NVST) Purchased by Louisiana State Employees Retirement System
marketbeat.com - April 24 at 4:54 AM
Envista (NVST) Scheduled to Post Earnings on WednesdayEnvista (NVST) Scheduled to Post Earnings on Wednesday
americanbankingnews.com - April 24 at 3:08 AM
Envista Holdings Co. (NYSE:NVST) Receives Average Recommendation of "Hold" from BrokeragesEnvista Holdings Co. (NYSE:NVST) Receives Average Recommendation of "Hold" from Brokerages
americanbankingnews.com - April 24 at 2:36 AM
Envista Holdings Corporation (NVST)Envista Holdings Corporation (NVST)
finance.yahoo.com - April 23 at 8:35 AM
Foundry Partners LLC Makes New $3.57 Million Investment in Envista Holdings Co. (NYSE:NVST)Foundry Partners LLC Makes New $3.57 Million Investment in Envista Holdings Co. (NYSE:NVST)
marketbeat.com - April 23 at 7:35 AM
Envista Holdings Co. (NYSE:NVST) Shares Sold by North Star Asset Management Inc.Envista Holdings Co. (NYSE:NVST) Shares Sold by North Star Asset Management Inc.
marketbeat.com - April 22 at 11:35 AM
Envista Holdings Co. (NYSE:NVST) Shares Sold by SG Americas Securities LLCEnvista Holdings Co. (NYSE:NVST) Shares Sold by SG Americas Securities LLC
marketbeat.com - April 20 at 4:12 AM
Envista Holdings: Navigating Leadership Changes and Long-Term Turnaround ChallengesEnvista Holdings: Navigating Leadership Changes and Long-Term Turnaround Challenges
markets.businessinsider.com - April 18 at 7:55 AM
River Road Asset Management LLC Buys New Holdings in Envista Holdings Co. (NYSE:NVST)River Road Asset Management LLC Buys New Holdings in Envista Holdings Co. (NYSE:NVST)
marketbeat.com - April 17 at 4:41 PM
Envista (NYSE:NVST) Stock Price Up 3.7%Envista (NYSE:NVST) Stock Price Up 3.7%
marketbeat.com - April 16 at 3:43 PM
Envista Holdings Corporation: Envista Announces CEO AppointmentEnvista Holdings Corporation: Envista Announces CEO Appointment
finanznachrichten.de - April 16 at 7:43 AM
Envista Holdings Co. (NYSE:NVST) Shares Purchased by Mutual of America Capital Management LLCEnvista Holdings Co. (NYSE:NVST) Shares Purchased by Mutual of America Capital Management LLC
marketbeat.com - April 16 at 5:44 AM
Envista Names Paul Keel CEOEnvista Names Paul Keel CEO
markets.businessinsider.com - April 15 at 9:12 PM
Envista Taps Former Smiths Group Chief Paul Keel as Next CEOEnvista Taps Former Smiths Group Chief Paul Keel as Next CEO
marketwatch.com - April 15 at 7:18 PM
Envista Announces New CEOEnvista Announces New CEO
ocbj.com - April 15 at 7:18 PM
Envista Announces CEO AppointmentEnvista Announces CEO Appointment
finance.yahoo.com - April 15 at 7:18 PM
Envista (NYSE:NVST) Reaches New 1-Year Low at $19.73Envista (NYSE:NVST) Reaches New 1-Year Low at $19.73
marketbeat.com - April 12 at 10:54 AM
Envista Smile Project Donates $1.2 Million in 2023Envista Smile Project Donates $1.2 Million in 2023
prnewswire.com - April 11 at 4:10 PM
Raymond James & Associates Has $9.82 Million Holdings in Envista Holdings Co. (NYSE:NVST)Raymond James & Associates Has $9.82 Million Holdings in Envista Holdings Co. (NYSE:NVST)
marketbeat.com - April 6 at 4:23 AM
Envista Schedules First Quarter 2024 Earnings CallEnvista Schedules First Quarter 2024 Earnings Call
finance.yahoo.com - April 4 at 5:23 PM
DAVENPORT & Co LLC Invests $13.23 Million in Envista Holdings Co. (NYSE:NVST)DAVENPORT & Co LLC Invests $13.23 Million in Envista Holdings Co. (NYSE:NVST)
marketbeat.com - April 3 at 8:19 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bitcoin Group logo

Bitcoin Group

OTCMKTS:BTGGF
Bitcoin Group SE, an investment holding company, engages in the cryptocurrency and blockchain businesses worldwide. The company operates a trading platform for the digital currency bitcoin under the Bitcoin.de. It also provides financial services. The company was founded in 2008 and is based in Herford, Germany. Bitcoin Group SE is a subsidiary of Priority AG.
Integra LifeSciences logo

Integra LifeSciences

NASDAQ:IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
NeoGenomics logo

NeoGenomics

NASDAQ:NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Envista logo

Envista

NYSE:NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.